WO2008081473A3 - Process for preparing clopidogrel - Google Patents

Process for preparing clopidogrel Download PDF

Info

Publication number
WO2008081473A3
WO2008081473A3 PCT/IN2007/000612 IN2007000612W WO2008081473A3 WO 2008081473 A3 WO2008081473 A3 WO 2008081473A3 IN 2007000612 W IN2007000612 W IN 2007000612W WO 2008081473 A3 WO2008081473 A3 WO 2008081473A3
Authority
WO
WIPO (PCT)
Prior art keywords
acid
thieno
pyridin
acetamide
chlorophenyl
Prior art date
Application number
PCT/IN2007/000612
Other languages
French (fr)
Other versions
WO2008081473A2 (en
Inventor
Niraj Shyamlal Shah
Shriprakash Dhar Dwivedi
Original Assignee
Cadila Healthcare Ltd
Niraj Shyamlal Shah
Shriprakash Dhar Dwivedi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd, Niraj Shyamlal Shah, Shriprakash Dhar Dwivedi filed Critical Cadila Healthcare Ltd
Publication of WO2008081473A2 publication Critical patent/WO2008081473A2/en
Publication of WO2008081473A3 publication Critical patent/WO2008081473A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Abstract

A process for the preparation of clopidogrel of formula (I) or its pharmaceutically acceptable salts, solvates, hydrates thereof is disclosed. The process comprises treating (+)-(S)-2-Chlorophenyl-(6,7-dihydro-4H-thieno[3,2- c]pyridin-5-yl)acetamide of formula (II) with acid to provide novel acid salt of (+)-(S)- 2-Chlorophenyl-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetamide of formula (III) wherein in S represent acid selected from hydrochloric acid, hydrobromic acid, phosphoric acid, benzoic acid, succinic acid, oxalic acid, malic acid, maleic acid, methanesulfonic acid, ethane sulfonic acid, benzenesulfonic acid, p-toluene sulfonic acid, nephthalene sulfonic acid and converting acid salt of (+)-(S)-2-Chlorophenyl- (6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetamide to Clopidogrel (I) and its pharmaceutically acceptable salts, hydrates, solvates thereof.
PCT/IN2007/000612 2006-12-29 2007-12-27 Process for preparing clopidogrel WO2008081473A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2165/MUM/2006 2006-12-29
IN2165MU2006 2006-12-29

Publications (2)

Publication Number Publication Date
WO2008081473A2 WO2008081473A2 (en) 2008-07-10
WO2008081473A3 true WO2008081473A3 (en) 2008-11-20

Family

ID=39472559

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2007/000612 WO2008081473A2 (en) 2006-12-29 2007-12-27 Process for preparing clopidogrel

Country Status (1)

Country Link
WO (1) WO2008081473A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020177712A1 (en) * 2001-01-24 2002-11-28 Cadila Healthcare Limited Process to prepare clopidogrel
WO2005026174A1 (en) * 2003-09-11 2005-03-24 Generics [Uk] Limited Novel crystalline polymorphs of clopidogrel
US20050256152A1 (en) * 2003-02-13 2005-11-17 Karlheinz Doser Salt of a sulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations
WO2007144895A1 (en) * 2006-06-12 2007-12-21 Cadila Healthcare Limited Process for the preparation of (s) - (+)-clopidogrel

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020177712A1 (en) * 2001-01-24 2002-11-28 Cadila Healthcare Limited Process to prepare clopidogrel
US20050256152A1 (en) * 2003-02-13 2005-11-17 Karlheinz Doser Salt of a sulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations
WO2005026174A1 (en) * 2003-09-11 2005-03-24 Generics [Uk] Limited Novel crystalline polymorphs of clopidogrel
WO2007144895A1 (en) * 2006-06-12 2007-12-21 Cadila Healthcare Limited Process for the preparation of (s) - (+)-clopidogrel

Also Published As

Publication number Publication date
WO2008081473A2 (en) 2008-07-10

Similar Documents

Publication Publication Date Title
WO2007125544A3 (en) Process for the preparation of polymorphic forms of clopidogrel hydrogen sulfate
MX2010004260A (en) Thienopyrimidine and pyrazolopyrimidine compounds and their use as mtor kinase and pi3 kinase inhibitors.
NZ594508A (en) [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors
GEP20094633B (en) 1H-THIENO[2,3-c]PYRAZOLE DERIVATIVES USEFUL AS KINASE INHIBITORS
IL189667A0 (en) 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives
EA201001548A1 (en) ACID SULFATE 2-ACETOXY-5- (α-CYCLOPROPILCARBONYL-2-FLUORBENZYL) -4,5,6,7-TETRAHYDROTHIENO [3,2-c] Pyridine and its production
WO2009100333A3 (en) Sweetener compositions and methods of making them
HK1159628A1 (en) Thieno[3,2-c]pyridine derivatives as kinase inhibitors for use in the treatment of cancer [32- c]
UA99447C2 (en) Process for the preparation of sildenafil
WO2011038185A3 (en) Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors
TW200745137A (en) Thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
WO2008081282A3 (en) Process for the synthesis of n9-(3,5-dichloro-4-pyridyl)-6- difluoromethoxybenzo(4,5)furo(3,2-c)pyridine-9-carboxamide and salts thereof
WO2009047775A3 (en) Polymorphs of esomeprazole salts
WO2005090359A3 (en) Synthesis of 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno[2, 3-b][1,5]benzodiazepine and salts thereof
NI200800021A (en) DERIVATIVES OF N - (ARYLALKYL) - 1H - PYRROLOPYRIDIN - 2 - CARBOXAMIDES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS
WO2008081473A3 (en) Process for preparing clopidogrel
IL192825A0 (en) A PROCESS FOR THE PREPARATION OF POLYMORPH FORM I OF (S)-(+)-METHYL-ßé?- (2-CHLOROPHENYL)-6,7-DYHIDRO-THIENO-[3,2-C]PYRIDINE-5(4H)-ACETATE HYDROGEN SULFATE
AU2002336211A1 (en) A process for preparing enantiomerically pure alpha-phenyl-alpha-(6,7-dihydro-4h-thieno(3,2-c)pyridin-5-yl)-acetic acid derivatives
WO2006074919A3 (en) 3-AMINO-6-ARYL(OR 6-HETEROARYL)-THIENO[2,3-B]PYRIDIN-2-CARBOXAMIDES, PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AND THEIR USE AS TNFα INHIBITORS
IL164978A0 (en) A process for the preparation of clopidogrel
WO2011092720A3 (en) Pharmaceutical composition of prasugrel and its pharmaceutically acceptable salts and process for their preparation
EA200701770A1 (en) METHOD OF RACEMIZATION OF R (-) ISOMER OF METHYL ETHER (2-CHLORPHENYL) -6,7-DIHYDROTHIENO [3,2-c] PYRIDIN-5 (4H) -CATIC ACID
WO2011042765A8 (en) Inorganic salt complexes of vildagliptin
WO2008107543A3 (en) Derivatives of pyrrolopyridine-2-carboxamids, preparation thereof and therapeutic application thereof
WO2008054796A3 (en) Triazolopyrimidine derivatives as adp p2y12 receptor antagonists

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07870566

Country of ref document: EP

Kind code of ref document: A2

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07870566

Country of ref document: EP

Kind code of ref document: A2